REICIN ALISE
Insider transactions at 1 company
This page shows all SEC Form 4 filings attributed to REICIN ALISE. Form 4 disclosures are required whenever a corporate insider — director, officer, or 10%+ shareholder — buys, sells, or receives company stock. Each row represents a separate reported transaction. All data is sourced directly from the SEC EDGAR public database.
| Company | Title | Type | Shares | Price | Value | Date |
|---|---|---|---|---|---|---|
| TECX | Chief Executive Officer | Award / Grant | 14,700 | — | — | Sep 25, 2025 |
| TECX | Chief Executive Officer | Tax Withholding | 859 | $19.81 | $17,017 | Jun 20, 2025 |
| TECX | Chief Executive Officer | Award / Grant | 36,047 | — | — | Feb 4, 2025 |
| TECX | Chief Executive Officer | Award / Grant | 11,717 | — | — | Dec 4, 2024 |
| TECX | Chief Executive Officer | Award / Grant | 124,530 | — | — | Jun 20, 2024 |
| 0000816284 | PRES., GLOBAL CLINICAL DEV. | Disposition | 44,615 | — | — | Nov 20, 2019 |
| 0000816284 | PRES., GLOBAL CLINICAL DEV. | Tax Withholding | 4,722 | $108.53 | $512,479 | Nov 1, 2019 |